NTRA · XBRL financial data

Natera financial statements, every fiscal year

The same tables from 6 filings, lined up. Matched by XBRL tag: renamed lines keep their history.

How these numbers work

Every number comes from the company's XBRL financial data filed with the SEC, and each one links to its filing.
Lines are matched by XBRL tag, so a line renamed between filings keeps its history.
* marks a quarter worked out from the filing totals: the 10-K year minus the first three quarters, or a year-to-date total minus the earlier one. Fourth-quarter earnings per share is fourth-quarter net income over the fourth-quarter weighted shares.
0 means a filing states zero; a dash (—) means no filing states that number.
“year only” means the 10-K gives the full year but not the quarters needed to work out the fourth. A worked-out quarter of revenue, cost of revenue or operating cash flow more than twice the company's largest quarter of the two years before is shown this way too.
Gross profit is shown as the company reports it; a worked-out quarter must equal revenue less cost of revenue for that quarter, or it is a dash.
Operating income can be above gross profit when the company books other operating income between the two, shown on its own line.
Shares outstanding come from each filing's cover page, as of the date printed there.
Quarters are fiscal: Q2 FY27 is the second quarter of the company's fiscal 2027.

Income statement

Fiscal years (NTRA's year ends in late December)

In millions of dollars	FY 2020Dec 31, 2020	FY 2021Dec 31, 2021	FY 2022Dec 31, 2022	FY 2023Dec 31, 2023	FY 2024Dec 31, 2024	FY 2025Dec 31, 2025
Revenue from contracts with customers	391	625	820	1,083	1,697	2,306
Research and development	100	264	316	321	404	624
Selling, general and administrative	304	511	589	618	841	1,177
Operating income (loss)	(216)	(468)	(541)	(446)	(222)	(310)
Interest expense	15	8	9	13	11	4
Income tax expense (benefit)	0	1	1	0	1	(60)
Net income (loss)	(230)	(472)	(548)	(435)	(190)	(208)
Earnings per share, basic USD per share	(2.84)	(5.21)	(5.57)	(3.78)	(1.53)	(1.52)
Earnings per share, diluted USD per share	(2.84)	(5.21)	(5.57)	(3.78)	(1.53)	(1.52)
Weighted average shares, basic millions of shares	81	91	98	115	125	137
Weighted average shares, diluted millions of shares	81	91	98	115	125	137

Fiscal years (NTRA's year ends in late December)

In millions of dollars	FY 2020Dec 31, 2020	FY 2021Dec 31, 2021	FY 2022Dec 31, 2022	FY 2023Dec 31, 2023	FY 2024Dec 31, 2024	FY 2025Dec 31, 2025
Cash and cash equivalents	49	84	466	642	946	1,076
Marketable securities	689	830	432	237	23	—
Accounts receivable	79	122	244	278	314	297
Inventory	20	27	35	41	45	68
Prepaid and other current assets	27	30	34	61	49	56
Total current assets	863	1,093	1,212	1,259	1,376	1,497
Property and equipment, net	33	66	92	111	162	241
Right-of-use asset	21	59	72	57	86	109
Goodwill	—	—	—	—	—	141
Total assets	932	1,236	1,394	1,442	1,661	2,398
Accounts payable	8	27	31	15	35	33
Accrued liabilities	60	—	—	—	—	—
Total current liabilities	199	219	310	307	344	441
Lease liability, non-current	21	61	77	67	97	118
Total liabilities	446	583	689	676	465	686
Accumulated deficit	(929)	(1,395)	(1,943)	(2,377)	(2,568)	(2,776)
Total stockholders' equity	486	653	706	765	1,195	1,712
Total liabilities and equity	932	1,236	1,394	1,442	1,661	2,398
Common shares outstanding (cover page) millions of shares	87	95	113	121	135	142

Fiscal years (NTRA's year ends in late December)

In millions of dollars	FY 2020Dec 31, 2020	FY 2021Dec 31, 2021	FY 2022Dec 31, 2022	FY 2023Dec 31, 2023	FY 2024Dec 31, 2024	FY 2025Dec 31, 2025
Net income (loss)	(230)	(472)	(548)	(435)	(190)	(208)
Stock-based compensation	50	115	152	192	274	354
Depreciation and amortization	9	11	17	24	31	42
Net cash from operating activities	(183)	(335)	(432)	(247)	136	215
Purchases of property and equipment	20	41	48	39	66	106
Net cash from investing activities	(331)	(205)	330	168	138	(132)
Net cash from financing activities	501	576	483	254	30	47

SIC 8071 and related industry codes, similar size. Each row is the latest quarter reported.

How peers are chosen

SIC 8071 and related industry codes with public float (or, where float is missing, quarterly revenue) between 0.2x and 5x the company's.
Each row is the latest quarter the company has reported, named in the Quarter column; when that filing is a 10-K, it is the fourth quarter, never the full year.
Runway shows only for companies burning cash with under $10B of public float.
* marks a quarter worked out from the filing totals: for a 10-K, the year less the first three quarters; for a 10-Q, the year-to-date total less the earlier one.

Company	Cash ($M)	Revenue, quarter ($M)	Operating cash flow, quarter ($M)	Shares outstanding	Runway	Quarter
Natera	1,092	753	55*	144.1M	—	Q2 FY26 10-QJun 30, 2026
Labcorp Holdings	262	3,810	564*	81.2M	—	Q3 FY26 10-QSep 30, 2026
Quest Diagnostics	797	3,097	611*	110.0M	—	Q3 FY26 10-QSep 30, 2026
Exact Sciences	956	878*	152*	190.9M	—	Q4 FY25 10-KDec 31, 2025
Lumexa Imaging Holdings	70	264	33*	96.1M	—	Q2 FY26 10-QJun 30, 2026
Guardant Health	1,053	335	(58)*	134.2M	18.2 quarters	Q2 FY26 10-QJun 30, 2026

Not investment advice. Not affiliated with the U.S. SEC.